A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Clinical trial NCT05743881 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05743881
Sponsor: ModernaTX, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Human Metapneumovirus

Start date: 2023-02-15
Primary completion: 2029-08-31
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.